Table II.
Patients’ Distribution According to Number and Class of Additional Antihypertensive Drugs Being Taken at Each Time Point of BP Determination (1 or 2 and 12 Weeks of Treatment)
| Early BP Determination Group | Standard BP Determination Group | |||
|---|---|---|---|---|
| 1 Week (n=331) | 12 Weeks (n=186) | 2 Weeks (n=1890) | 12 Weeks (n=1372) | |
| No. | ||||
| 0 | 330 (99.7) | 161 (86.6) | 1856 (98.2) | 1187 (86.5) |
| 1 | 1 (0.3) | 20 (10.8) | 33 (1.7) | 163 (11.9) |
| 2 | 0 (0.0) | 5 (2.7) | 1 (0.1) | 21 (1.5) |
| 3 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.1) |
| ≥4 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Class | ||||
| Diuretic | 0 (0.0) | 5 (2.7) | 9 (0.5) | 35 (2.6) |
| α‐Blocker | 0 (0.0) | 2 (1.1) | 1 (0.1) | 10 (0.7) |
| β‐Blocker | 0 (0.0) | 1 (0.5) | 1 (0.1) | 14 (1.0) |
| CCB | 1 (0.3) | 20 (10.8) | 23 (1.2) | 144 (10.5) |
| ACE inhibitor | 0 (0.0) | 0 (0.0) | 1 (0.1) | 4 (0.3) |
| ARB | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Other | 0 (0.0) | 2 (1.1) | 0 (0.0) | 0 (0.0) |
Abbreviations: ACE, angiotensin‐converting enzyme; ARB, angiotensin II type 1 receptor blocker; BP, blood pressure; CCB, calcium channel blocker. Values are No. (%). The patients’ distribution represents that in 1 day prior to BP determination at 1, 2, and 12 weeks.